Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission

Sexually Transmitted Diseases

Volumn 42, Issue 10, 2015, Pages 554-565

  Adachi, Kristina ^a   Klausner, Jeffrey D ^a   Bristow, Claire C ^b   Xu, Jiahong ^c   Ank, Bonnie ^a   Morgado, Mariza G ^d   Watts, D Heather ^e   Weir, Fred ^f   Persing, David ^f   Mofenson, Lynne M ^g   Veloso, Valdilea G ^d   Pilotto, Jose Henrique ^h   Joao, Esau ⁱ   Nielsen Saines, Karin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WESTAT   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e U S DEPARTMENT OF STATE   (United States)

^f CEPHEID   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h Hospital Geral de Nova Iguacu   (Brazil)

ⁱ Hospital Federal dos Servidores do Estado   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DEMOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; MAJOR CLINICAL STUDY; MIXED INFECTION; MULTICENTER STUDY (TOPIC); NEISSERIA GONORRHOEAE; PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL STATUS; URINALYSIS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; ARGENTINA; BRAZIL; CHLAMYDIA INFECTIONS; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOTHER; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POST EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SOUTH AFRICA; TRANSMISSION; UNITED STATES;

ADULT; ARGENTINA; BRAZIL; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HIV SEROPOSITIVITY; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; POST-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; PREVALENCE; RISK FACTORS; SOUTH AFRICA; UNITED STATES;

EID: 84941780021     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000340     Document Type: Article

References (48)

1. World Health Organization DoRHaR. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008. Geneva, Switzerland: World Health Organization; 2012.
2. Silveira MF, Ghanem KG, Erbelding EJ, et al. Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: A casecontrol study. Int J STD AIDS 2009; 20:465-469.
3. Woods CR. Gonococcal infections in neonates and young children. Semin Pediatr Infect Dis 2005; 16:258-270.
4. Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin Infect Dis 2011; 53(suppl 3):S99-S102.
5. OrganizationWH. Global Strategy for Prevention and Control of Sexually Transmitted Infections: 2006-2105. Geneva, Switzerland:World Health Organization, 2006.
6. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginalHIVshedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997; 11:F85-F93.
7. McClelland RS,Wang CC,Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15:105-110.
8. Wabwire-Mangen F, Gray RH, Mmiro FA, et al. Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. J Acquir Immune Defic Syndr 1999; 22:379-385.
9. Taha TE, Brown ER, Hoffman IF, et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS 2006; 20:1313-1321.
10. Goldenberg RL, Vermund SH, Goepfert AR, et al. Choriodecidual inflammation: A potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998; 352:1927-1930.
11. Goldenberg RL, Mudenda V, Read JS, et al. HPTN 024 study: Histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. Am J Obstet Gynecol 2006; 195:1065-1074.
12. Mwanyumba F, Gaillard P, Inion I, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 2002; 29:262-269.
13. King CC, Ellington SR, Kourtis AP. The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res 2013; 11:10-23.
14. Chi BH,Mudenda V, Levy J, et al. Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. Am J Obstet Gynecol 2006; 194:174-181.
15. Taha TE, Gray RH. Genital tract infections and perinatal transmission of HIV. Ann N YAcad Sci 2000; 918:84-98.
16. FawziW, Msamanga G, Renjifo B, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 2001; 15:1157-1165.
17. Chaisilwattana P, Chuachoowong R, Siriwasin W, et al. Chlamydial and gonococcal cervicitis in HIV-seropositive and HIV-seronegative pregnant women in Bangkok: Prevalence, risk factors, and relation to perinatal HIV transmission. Sex Transm Dis 1997; 24:495-502.
18. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 1999; 353: 525-535.
19. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209-1217.
20. Nielsen-Saines K,Watts DH, Veloso VG, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012; 366:2368-2379.
21. Jalil EM, Pinto VM, Benzaken AS, et al. Prevalence of Chlamydia and Neisseria gonorrhoeae infections in pregnant women in six Brazilian cities. Rev Bras Ginecol Obstet 2008; 30:614-619.
22. Yeganeh N, Watts HD, Camarca M, et al. Syphilis in HIV-infected mothers and infants: Results from the NICHD/HPTN 040 study. Pediatr Infect Dis J 2015; 34:e52-e57.
23. Pinto VM, Szwarcwald CL, Baroni C, et al. Chlamydia trachomatis prevalence and risk behaviors in parturient women aged 15 to 24 in Brazil. Sex Transm Dis 2011; 38:957-961.
24. Travassos AG, Brites C, Netto EM, et al. Prevalence of sexually transmitted infections among HIV-infected women in Brazil. Braz J Infect Dis 2012; 16:581-585.
25. ChicoRM,Mayaud P, Ariti C, et al. Prevalence ofmalaria and sexually transmitted and reproductive tract infections in pregnancy in sub- Saharan Africa: A systematic review. JAMA 2012; 307:2079-2086.
26. Marx G, John-Stewart G, Bosire R, et al. Diagnosis of sexually transmitted infections and bacterial vaginosis among HIV-1-infected pregnant women in Nairobi. Int J STD AIDS 2010; 21:549-552.
27. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
28. LeFevre ML. Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014; 161:902-910.
29. Sullivan EA, Koro S, Tabrizi S, et al. Prevalence of sexually transmitted diseases and human immunodeficiency virus among women attending prenatal services in Apia, Samoa. Int J STD AIDS 2004; 15: 116-119.
30. Maupin R Jr, Lyman R, Fatsis J, et al. Characteristics of women who deliver with no prenatal care. J Matern Fetal Neonatal Med 2004; 16:45-50.
31. Silveira MF, Erbelding EJ, Ghanem KG, et al. Risk of Chlamydia trachomatis infection during pregnancy: Effectiveness of guidelinesbased screening in identifying cases. Int J STD AIDS 2010; 21: 367-370.
32. Hwang LY, RossMW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000; 31:920-926.
33. March of Dimes P, Save the Children, WHO. Born Too Soon: The Global Action Report on Preterm Birth. In: CP Howson MK, Lawn JE, eds. Geneva, Switzerland: World Health Organization; 2012.
34. Lawn JE, Blencowe H, Pattinson R, et al. Stillbirths: Where? When? Why? How to make the data count? Lancet 2011; 377:1448-1463.
35. Chi BH,Wang L, Read JS, et al. Predictors of stillbirth in sub-Saharan Africa. Obstet Gynecol 2007; 110:989-997.
36. Donders GG, Desmyter J, De Wet DH, et al. The association of gonorrhoea and syphilis with premature birth and low birthweight. Genitourin Med 1993; 69:98-101.
37. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005; 16:235-244.
38. Baud D, Regan L, Greub G. Emerging role of chlamydia and chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis 2008; 21:70-76.
39. Korenromp EL, White RG, Orroth KK, et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: A synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005; 191(suppl 1): S168-S178.
40. Goldenberg RL,Mwatha A, Read JS, et al. The HPTN 024 Study: The efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol 2006; 194:650-661.
41. Thorne C, Newell ML. Prevention of mother-to-child transmission of HIV infection. Curr Opin Infect Dis 2004; 17:247-252.
42. RotchfordK, StrumAW,Wilkinson D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: Systematic review and data synthesis. Sex Transm Dis 2000; 27:243-248.
43. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis. Sex Transm Dis 2008; 35:946-959.
44. Chen KT, Segu M, Lumey LH, et al. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstet Gynecol 2005; 106:1341-1348.
45. Drake AL, John-Stewart GC,Wald A, et al. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission. Obstet Gynecol 2007; 109(2 Pt 1):403-409.
46. Yeganeh N, Watts DH, Camarca M, et al. Syphilis in HIV-infected mothers and infants: Results from the NICHD/HPTN 040 Study. Abstract #543 21st Conference on Retroviruses and Opportunistic Infections; Boston, MA, March 3-6, 2014.
47. Nielsen-Saines K, for NICHD HPTN 040 Protocol Team. Increased CMV co-infection with in utero-acquired HIV-1. Oral abstract #2695.8. PediatricAcademic SocietyMeetings,May 4-7, 2013;Washington, DC.
48. Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet 1998; 351(suppl 3):5-7.